| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 50,716 | 60,973 | 57,260 | 48,138 | | Cost of Revenue | 18,690 | 21,326 | 18,187 | 13,474 | | | Gross Profit | 32,026 | 39,647 | 39,073 | 34,664 | | | Operating Expenses | | Research Development | 1,673 | 1,561 | 1,608 | 1,356 | | Selling General and Administrative | 34,964 | 31,004 | 30,516 | 35,338 | | Non Recurring | 78 | 2,825 | 842 | 1,147 | | Others | 2,753 | 3,005 | 2,927 | 3,156 | | | | Total Operating Expenses | 39,468 | 38,395 | 35,893 | 40,997 | | | | Operating Income or Loss | (7,442) | 1,252 | 3,180 | (6,333) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9 | 27 | 48 | 121 | | Earnings Before Interest And Taxes | (7,433) | 1,279 | 3,228 | (6,212) | | Interest Expense | 149 | 151 | 151 | 153 | | Income Before Tax | (7,582) | 1,128 | 3,077 | (6,365) | | Income Tax Expense | (182) | 386 | (83) | 641 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,400) | 742 | 3,160 | (7,006) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,400) | 742 | 3,160 | (7,006) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,400) | $742 | $3,160 | ($7,006) |
|
0.26% Nasdaq 
0.59%
Income Statement
